Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Chunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.
Chemical Society Reviews (2015) Vol. 44, Iss. 22, pp. 8238-8259
Closed Access | Times Cited: 148

Showing 51-75 of 148 citing articles:

A Bionic‐Homodimerization Strategy for Optimizing Modulators of Protein–Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation
Jin Yan, Xiaoqiang Zheng, Weiming You, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 19
Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far
Ahmed Elwakeel
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 19
Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein
Lorenzo Calugi, Giulia Sautariello, Elena Lenci, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115118-115118
Open Access | Times Cited: 10
Macromolecular crowding effect on the β-galactosidase cascade reaction under multivalency and chain overlapping conditions of glycopolymers
Wen Li, Jinxia Zheng, Z Ke, et al.
International Journal of Biological Macromolecules (2025) Vol. 313, pp. 144343-144343
Closed Access
Protein–protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics
L. Carro
Beilstein Journal of Organic Chemistry (2018) Vol. 14, pp. 2881-2896
Open Access | Times Cited: 30
Allosteric Modulators of Protein–Protein Interactions (PPIs)
Duan Ni, Na Liu, Chunquan Sheng
Advances in experimental medicine and biology (2019), pp. 313-334
Closed Access | Times Cited: 29
Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
Ke‐Jia Wu, Pui-Man Lei, Hao Liu, et al.
Molecules (2019) Vol. 24, Iss. 24, pp. 4428-4428
Open Access | Times Cited: 28
Selected Approaches to Disrupting Protein–Protein Interactions within the MAPK/RAS Pathway
Stephen J. Harwood, Christopher R. Smith, J. David Lawson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7373-7373
Open Access | Times Cited: 9
Programming interchangeable and reversible heterooligomeric protein self-assembly using a bifunctional ligand
Su-young Son, Woon Ju Song
Chemical Science (2024) Vol. 15, Iss. 8, pp. 2975-2983
Open Access | Times Cited: 3
Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer Drugs
Pankaj Garg, G. D. Singhal, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3884-3884
Open Access | Times Cited: 3
Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylators
Vincent Archambault, Karine Normandin
Cell Cycle (2017) Vol. 16, Iss. 12, pp. 1220-1224
Open Access | Times Cited: 27
Exploitation of the Ugi–Joullié reaction in drug discovery and development
Stefano Gazzotti, Giulia Rainoldi, Alessandra Silvani
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 7, pp. 639-652
Closed Access | Times Cited: 25
A new strategy for the in vitro selection of stapled peptide inhibitors by mRNA display
Emil S. Iqbal, Stacie L. Richardson, Nicolas Abrigo, et al.
Chemical Communications (2019) Vol. 55, Iss. 61, pp. 8959-8962
Open Access | Times Cited: 25
Engineered protein scaffolds as leads for synthetic inhibitors of protein–protein interactions
Michael Wuo, Paramjit S. Arora
Current Opinion in Chemical Biology (2018) Vol. 44, pp. 16-22
Open Access | Times Cited: 24
Applications of Solution NMR in Drug Discovery
Shi Li, Naixia Zhang
Molecules (2021) Vol. 26, Iss. 3, pp. 576-576
Open Access | Times Cited: 19
Screening-based approaches to identify small molecules that inhibit protein–protein interactions
Sehee Choi, Kang‐Yell Choi
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 3, pp. 293-303
Closed Access | Times Cited: 24
Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells
Yijiang Shi, Tracy R. Daniels‐Wells, Patrick Frost, et al.
Cancer Research (2016) Vol. 76, Iss. 19, pp. 5822-5831
Open Access | Times Cited: 22
Flexibility is important for inhibition of the MDM2/p53 protein–protein interaction by cyclic β-hairpins
Emma Danelius, Mariell Pettersson, Matilda Bred, et al.
Organic & Biomolecular Chemistry (2016) Vol. 14, Iss. 44, pp. 10386-10393
Closed Access | Times Cited: 22
In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 21
Bifunctional Ligands for Inhibition of Tight-Binding Protein–Protein Interactions
Taavi Ivan, Erki Enkvist, Birgit Viira, et al.
Bioconjugate Chemistry (2016) Vol. 27, Iss. 8, pp. 1900-1910
Open Access | Times Cited: 20
Methods for the Discovery and Identification of Small Molecules Targeting Oxidative Stress-Related Protein–Protein Interactions: An Update
Xuexuan Wu, Qiuyue Zhang, Yuqi Guo, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 619-619
Open Access | Times Cited: 12
Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization
Agnès Quéméner, Mike Maillasson, Laurence Arzel, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 14, pp. 6249-6272
Closed Access | Times Cited: 21
Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
Andrew F. Voter, James L. Keck
Advances in protein chemistry and structural biology (2017), pp. 197-222
Open Access | Times Cited: 20
Mdm2 inhibitors as a platform for the design of P-glycoprotein inhibitors
Tatyana A. Grigoreva, Angelina Romanova, Aleksandra Sagaidak, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 30, Iss. 18, pp. 127424-127424
Closed Access | Times Cited: 18
Using machine‐learning‐driven approaches to boost hot‐spot's knowledge
Nícia Rosário‐Ferreira, Alexandre M. J. J. Bonvin, Irina S. Moreira
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 11

Scroll to top